We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Reclassifies Apple’s ECG App into Lower-Risk Class II, Special Controls
FDA Reclassifies Apple’s ECG App into Lower-Risk Class II, Special Controls
Apple’s electrocardiograph (ECG) software for over-the-counter use, available as an app, has received a risk downgrade from the FDA to class II (special controls) as opposed to the highest-risk class III category.